| 2025 | Dementia, including Alzheimer’s disease | F01, F03, G30, G31.0, G31.8 | Added G31.0 and G31.8 to capture deaths from frontotemporal dementia or Lewy body dementia which have recorded increasing numbers of deaths over time. These codes are already included in statistical outputs published in Provisional Mortality Statistics and the AIHW report Dementia, Australia. |
| 2025 | Malignant neoplasm of renal pelvis, bladder and other urinary organs | C65 – C68 | Expanded from C67 (bladder cancers) to ensure a more complete measure of mortality from cancers of the urinary system. |
| 2025 | Malignant neoplasms of head and neck | C00-C14, C30-C32, C76.0 | Expanded from C32 (larynx cancer) to better reflect the broader burden of head and neck cancers. The changes incorporate oral cancers (C00-C14), cancers of other head and neck sites (C30-C32), and ill-defined cancers of the head, face and neck (C76.0). |
| 2025 | Malignant neoplasms of mesothelial tissue | C45 | Group created to capture Mesothelioma. Mesothelioma is separated from soft tissue neoplasms as it has independent risk factors. |
| 2025 | Malignant neoplasm of soft tissue | C46-C49 | Group created to capture Connective and soft tissue cancers. The larger grouping brings together all soft tissue malignancies. |
| 2025 | Malignant neoplasm, unknown primary so stated | C80.0 | Group created to capture cancers where the certifier has confirmed after investigation the site of the primary cancer is unknown. |
| 2025 | Obesity | E66 | Group created to capture obesity due to deaths increasing over time. |
| 2025 | Disorders of lipoprotein metabolism and other lipidaemias | E78 | Group created to capture Pure hypercholesterolaemia and Hyperlipidaemia, unspecified. This group has recorded an increasing number of deaths over time. |
| 2025 | Amyloidosis | E85 | Group created to capture amyloidosis. This group predominately contains cardiac amyloidosis. |
| 2025 | Systemic atrophies primarily affecting the central nervous system | G10-G14 | Group created to capture Motor neuron disease. The group was expanded to include all systematic atrophies primarily affecting the central nervous system. |
| 2025 | Extrapyramidal and movement disorders excluding Parkinson disease | G21-G26 | Group created to capture Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]. |
| 2025 | Selected peripheral vascular and arterial diseases | I72-I78 | Group created to capture Peripheral Vascular Disease and to recognise additional manifestations of poor cardiovascular health. |
| 2025 | Vascular disorders of intestines | K55 | Group created to recognise additional manifestations of poor cardiovascular health. |
| 2025 | Disorders of gallbladder, biliary tract and pancreas | K80-K87 | Group created to capture Cholangitis and Acute pancreatitis. |
| 2025 | Infections of the skin and subcutaneous tissue | L00-L08 | Group created to Cellulitis. The expanded group captures all infectious skin diseases. |
| 2024 | Accidental falls including fractures | W00-W19, X59.0 | Added code X59.0, Exposure to unspecified factor causing fracture to recognise different processes across jurisdictions for certifying deaths from a fall. |
| 2020 | COVID-19 | U071, U072, U10.9 | New codes introduced by WHO in response to the COVID-19 pandemic. |
| 2017 | Land transport accidents | V01-V89, Y85 | Expanded to include Y85 Sequelae transport accidents. |
| 2017 | Intentional self-harm [suicide] | X60-X84, Y87.0 | Expanded to include Y87.0 Sequelae of intentional self-harm. |
| 2017 | Assault [homicide] | X85-Y09, Y87.1 | Expanded to include Y87.1 Sequelae of assault. |
| 2015 | Malignant neoplasm of colon, sigmoid, rectum and anus | C18–C21, C26.0 | Added C26.0 for consistency across years. For more details, see Complexities in the measurement of bowel cancer in Australia. |
| 2009 | Influenza and pneumonia | J09-J18 | Added code J09, Influenza due to identified zoonotic or pandemic influenza virus. |